AI assistant
Sending…
RESMED INC — Director's Dealing 2025
Jun 3, 2025
30071_dirs_2025-06-03_88641782-d02e-449e-ac97-1a52cb5f8768.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2025-06-02
Reporting Person: Rider Michael J (Global General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-02 | ResMed Common Stock | S | 41 | $243.78 | Disposed | 8870 | Direct |
| 2025-06-02 | ResMed Common Stock | F | 267.244 | $244.79 | Disposed | 8603 | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025.
F2: Includes 64.6438 shares of ResMed stock purchased on April 30, 2025, through the ResMed Employee Stock Purchase Plan.
F3: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 06/01/2023.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29